High-density lipoprotein function - Recent advances

被引:220
作者
Ansell, BJ [1 ]
Watson, KE [1 ]
Fogelman, AM [1 ]
Navab, M [1 ]
Fonarow, GC [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Atherosclerosis Res Unit,Div Cardiol, Los Angeles, CA USA
关键词
D O I
10.1016/j.jacc.2005.06.080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although high-density lipoproteins (HDL) possess many features that contribute to the association between elevated HDL cholesterol and protection from atherosclerosis, these lipoproteins may be modified in certain individuals and/or circumstances to become proinflammatory. The ability of HDL to inhibit or paradoxically to enhance vascular inflammation, lipid oxidation, plaque growth, and thrombosis reflects changes in specific enzyme and protein components. The anti-inflammatory and proinflammatory functional properties of HDL can now be assessed using cell-based and cell-free assays. Acute or chronic systemic inflammation and the metabolic syndrome appear to render HDL proinflammatory. In contrast, statins and experimental agents such as apolipoprotein A-1 mimetics render HDL more anti-inflammatory. Functional characterization of HDL is a promising method for enhanced assessment of cardiovascular risk and effectiveness of risk reduction.
引用
收藏
页码:1792 / 1798
页数:7
相关论文
共 54 条
  • [31] Apolipoprotein A-I mimetic peptides
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Hama, S
    Hough, G
    Grijalva, VR
    Yu, N
    Ansell, BJ
    Datta, G
    Garber, DW
    Fogelman, AM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) : 1325 - 1331
  • [32] The double jeopardy of HDL
    Navab, M
    Ananthramaiah, GM
    Reddy, ST
    Van Lenten, BJ
    Ansell, BJ
    Hama, S
    Hough, G
    Bachini, E
    Grijalva, VR
    Wagner, AC
    Shaposhnik, Z
    Fogelman, AM
    [J]. ANNALS OF MEDICINE, 2005, 37 (03) : 173 - 178
  • [33] Oral D-4F causes formation of pre-β high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Hama, S
    Hough, G
    Grijalva, VR
    Wagner, AC
    Frank, JS
    Datta, G
    Garber, D
    Fogelman, AM
    [J]. CIRCULATION, 2004, 109 (25) : 3215 - 3220
  • [34] The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
    Navab, M
    Ananthramaiah, GM
    Reddy, ST
    Van Lenten, BJ
    Ansell, B
    Fonarow, GC
    Vahabzadeh, K
    Hama, S
    Hough, G
    Kamranpour, N
    Berliner, JA
    Lusis, A
    Fogelman, AM
    [J]. JOURNAL OF LIPID RESEARCH, 2004, 45 (06) : 993 - 1007
  • [35] Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol
    Navab, M
    Anantharamaiah, GM
    Hama, S
    Garber, DW
    Chaddha, M
    Hough, G
    Lallone, R
    Fogelman, AM
    [J]. CIRCULATION, 2002, 105 (03) : 290 - 292
  • [36] Oxidized lipids as mediators of coronary heart disease
    Navab, M
    Hama, SY
    Ready, ST
    Ng, CJ
    Van Lenten, BJ
    Laks, H
    Fogelman, AM
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (04) : 363 - 372
  • [37] HDL and the inflammatory response induced by LDL-derived oxidized phospholipids
    Navab, M
    Berliner, JA
    Subbanagounder, G
    Hama, S
    Lusis, AJ
    Castellani, LW
    Reddy, S
    Shih, D
    Shi, WB
    Watson, AD
    Van Lenten, BJ
    Vora, D
    Fogelman, AM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 481 - 488
  • [38] Myeloperoxidase and cardiovascular disease
    Nicholls, SJ
    Hazen, SL
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (06) : 1102 - 1111
  • [39] Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
    Nissen, SE
    Tsunoda, T
    Tuzcu, EM
    Schoenhagen, P
    Cooper, CJ
    Yasin, M
    Eaton, GM
    Lauer, MA
    Sheldon, WS
    Grines, CL
    Halpern, S
    Crowe, T
    Blankenship, JC
    Kerensky, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (17): : 2292 - 2300
  • [40] HDL and arteriosclerosis: beyond reverse cholesterol transport
    Nofer, JR
    Kehrel, B
    Fobker, M
    Levkau, B
    Assmann, G
    von Eckardstein, A
    [J]. ATHEROSCLEROSIS, 2002, 161 (01) : 1 - 16